Novo Nordisk A/S (NVO)
49.05
+2.69
(+5.80%)
USD |
NYSE |
Dec 10, 16:00
49.03
-0.02
(-0.04%)
Pre-Market: 20:00
Novo Nordisk Price: 49.05 for Dec. 10, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Evaxion AS | 6.37 |
| Ascendis Pharma A/S | 201.24 |
| Regeneron Pharmaceuticals, Inc. | 726.21 |
| Omeros Corp. | 11.24 |
| Viking Therapeutics, Inc. | 37.53 |
Price Related Metrics
| PE Ratio | 14.29 |
| PS Ratio | 4.680 |
| PEG Ratio | 1.262 |
| Price to Book Value | 10.75 |
| Price to Free Cash Flow | 23.63 |
| Earnings Yield | 7.00% |
| Market Cap | 217.95B |
| PEGY Ratio | 0.9627 |
| Operating PE Ratio | 11.03 |
| Normalized PE Ratio | 14.29 |